RhumbLine Advisers
PDSB icon

RhumbLine Advisers’s PDS Biotechnology PDSB Stock Holding History

RhumbLine Advisers’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,537
Closed -$33.8K – 4297
2024
Q2 		$33.8K Sell
11,537
-23,459
-67% -$75.1K ﹤0.01% 3780
2024
Q1 		$139K Buy
34,996
+1,201
+4% +$6.19K ﹤0.01% 3336
2023
Q4 		$168K Buy
33,795
+1,281
+4% +$6.37K ﹤0.01% 3268
2023
Q3 		$164K Buy
32,514
+1,510
+5% +$8.27K ﹤0.01% 3260
2023
Q2 		$156K Buy
+31,004
New +$203K ﹤0.01% 3362
2018
Q2 		– Sell
-878
Closed -$21K – 2924
2018
Q1 		$21K Buy
878
+31
+4% +$8.34K ﹤0.01% 2810
2017
Q4 		$159K Sell
847
-167
-16% -$33.6K ﹤0.01% 2691
2017
Q3 		$218K Buy
1,014
+16
+2% +$3.31K ﹤0.01% 2687
2017
Q2 		$205K Buy
998
+160
+19% +$31.5K ﹤0.01% 2748
2017
Q1 		$153K Buy
838
+38
+5% +$7.53K ﹤0.01% 2717
2016
Q4 		$200K Buy
800
+52
+7% +$11.8K ﹤0.01% 2673
2016
Q3 		$156K Buy
748
+85
+13% +$16.8K ﹤0.01% 2746
2016
Q2 		$134K Buy
+663
New +$117K ﹤0.01% 2863

Other funds holding PDSB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RhumbLine Advisers's PDSB Position: Q3 2024 in Review

RhumbLine Advisers sold out of PDS Biotechnology (PDSB) in Q3 2024, closing a stake of 11,537 shares — an estimated $33.8K sold.

RhumbLine Advisers first reported a position in PDSB in Q2 2016 and held it in 13 quarters. The position peaked at $218K in Q3 2017. 57 funds tracked by Wall St. Rank hold PDSB as of Q3 2024.

  • RhumbLine Advisers reported no remaining PDS Biotechnology position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 11,537 PDS Biotechnology shares in Q3 2024, an estimated $33.8K.
  • RhumbLine Advisers first reported a position in PDS Biotechnology in Q2 2016 and held it in 13 quarters.
  • RhumbLine Advisers's PDS Biotechnology position peaked at $218K in Q3 2017.
  • 57 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.